CrannMed

About CrannMed

CrannMed is a medical technology company developing resorbable embolisation therapies for chronic musculoskeletal conditions. Founded in 2018, CrannMed brings together world-leading expertise across clinical, material science and medical technology to advance next-generation resorbable microspheres designed to deliver therapeutic effect safely. While permanent microspheres have been used for decades in oncology and other embolisation procedures, resorbable embolisation opens new possibilities in musculoskeletal medicine including Knee Osteoarthritis, Adhesive Capsulitis (Frozen Shoulder) and Plantar Fasciitis - conditions affecting millions of patients worldwide.